Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Cancer|September 30, 2016
Clinical presentation and outcomes for adult ependymoma patientsAlvina A Acquaye, Elizabeth Vera, Mark R Gilbert, et al.Neuro-Oncology Practice|August 7, 2019
Relationship between symptom burden and health status: analysis of the MDASI-BT and EQ-5DElizabeth Vera, Alvina A Acquaye, Tito R Mendoza, et al.Neuro-Oncology|June 26, 2015
Hope and mood changes throughout the primary brain tumor illness trajectoryAlvina A Acquaye, Lin Lin, Elizabeth Vera-Bolanos, et al.Neuro-Oncology|August 21, 2015
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptomsTerri S Armstrong, Elizabeth Vera-Bolanos, Alvina A Acquaye, et al.Journal of Neuro-Oncology|September 12, 2012
Validation of the Mishel's uncertainty in illness scale-brain tumor form (MUIS-BT)Lin Lin, Alvina A Acquaye, Elizabeth Vera-Bolanos, et al.Cancer|May 11, 2013
Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modelingLin Lin, Hui-Hsun Chiang, Alvina A Acquaye, et al.Journal of Neuro-Oncology|March 26, 2015
Significant predictors of patients' uncertainty in primary brain tumorsLin Lin, Lung-Chang Chien, Alvina A Acquaye, et al.Journal of Patient-Reported Outcomes|August 25, 2019
Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviewsAlvina A Acquaye, Samuel S Payén, Elizabeth Vera, et al.Research Square|March 3, 2023
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trialAmanda L King, Alvina A Acquaye, Tito Mendoza, et al.BMC Cancer|March 22, 2023
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trialAmanda L King, Alvina A Acquaye-Mallory, Elizabeth Vera, et al.Pageof 3